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Background: Higher dietary salt intake increases the risk of stroke and may in-
crease white matter hyperintensity (WMH) volume. We hypothesized that a long-
term higher salt intake may be associated with other features of small vessel disease
(SVD). Methods: We recruited consecutive patients with mild stroke presenting
to the Lothian regional stroke service. We performed brain magnetic resonance
imaging, obtained a basic dietary salt history, and measured the urinary sodium/
creatinine ratio. We also carried out a systematic review to put the study in the
context of other studies in the field. Results: We recruited 250 patients, 112 with
lacunar stroke and 138 with cortical stroke, with a median age of 67.5 years. After
adjustment for risk factors, including age and hypertension, patients who had not
reduced their salt intake in the long term were more likely to have lacunar stroke
(odds ratio [OR], 1.90; 95% confidence interval [CI], 1.10-3.29), lacune(s) (OR, 2.06;
95% CI, 1.09-3.99), microbleed(s) (OR, 3.4; 95% CI, 1.54, 8.21), severe WMHs (OR,
2.45; 95% CI 1.34-4.57), and worse SVD scores (OR, 2.17; 95% CI, 1.22-3.9). There
was limited association between SVD and current salt intake or urinary sodium/
creatinine ratio. Our systematic review found no previously published studies of
dietary salt and SVD. Conclusion: The association between dietary salt and
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background SVD is a promising indication of a potential neglected contributory
factor for SVD. These results should be replicated in larger, long-term studies using
the recognized gold-standard measures of dietary sodium. Key Words: Dietary
salt—urinary sodium/creatinine ratio—white matter lesions—acute stroke.
© 2017 The Authors. Published by Elsevier Inc. on behalf of National Stroke
Association. This is an open access article under the CC BY license (http://
creativecommons.org/licenses/by/4.0/).
Introduction
Cerebral small vessel disease (SVD) is common and clin-
ically important: it is responsible for dementia,1 depression,2
physical disability,3 and one fifth of all strokes.4 On pa-
thology, there is an intrinsic disease of the small deep-
penetrating arteries with appearances described as
segmental arteriolar disorganization, fibrinoid necrosis,
and lipohylinosis.5 However, the etiology is unclear: while
common vascular risk factors such as hypertension are
very important, they only account for a small propor-
tion of the variance in SVD features.6
Previously, we found that increased dietary salt intake
was associated with greater white matter hyperintensity
(WMH) volumes, a key feature of SVD.7 Dietary salt also
increases the risk of any type of stroke: in 19 cohort studies
(n > 170,000 participants), the relative risk of stroke was
1.23 (95% confidence interval [CI], 1.06-1.4) for higher
versus lower salt intake,8 confirmed in the North Man-
hattan Stroke Study, which found a 17% increase in the
10-year stroke risk for each additional 500 mg of daily
dietary sodium.9
To further examine the potential relationship between
dietary salt intake and SVD clinical and imaging fea-
tures, we performed a cross-sectional study in patients
presenting with minor stroke and a systematic review of
the existing literature.
Materials and Methods
We recruited consecutive inpatients and outpatients pre-
senting to our regional stroke service with a minor ischemic
stroke from May 2010 to May 2012. We defined “minor”
as a stroke with a National Institutes of Health Stroke
Scale (NIHSS) score of 7 or lower at assessment and which
was not anticipated to cause impairment in activities of
daily living. The detailed recruitment and data collec-
tion procedure have been published previously.7,10
The study was approved by the Lothian Ethics of
Medical Research Committee (REC 09/81,101/54) and Na-
tional Health Service Lothian Research and Development
Office (2009/W/NEU/14) according to the Health Re-
search Authority, United Kingdom, which uses the
Declaration of Helsinki 1975 (revised in 1983), and all pa-
tients gave written informed consent.
All patients underwent magnetic resonance imaging
(MRI) as soon as possible after presentation (1.5 Tesla GE
Scanner, General Electric Medical Systems, Milwaukee,
USA) with T1, T2, T2*, fluid-attenuated inversion recov-
ery, and diffusion-weighted imaging sequences.
An experienced neuroradiologist (J.M.W.) reviewed
all imaging and classed the stroke lesion as “lacunar”
or “cortical” blind to clinical features; if no lesion was
present, the stroke syndrome was classified on clinical
findings based on the Bamford Classification.7 We
defined hypertension as either a previous diagnosis of
hypertension made prior to the stroke or a diagnosis of
hypertension made after presentation with stroke. All
patients had blood pressure (BP) recordings made
during their NHS clinical care. We recorded deep and
periventricular WMHs on the Fazekas Scale, and a total
SVD burden score (0-4) that incorporates microbleeds,
lacunes, periventricular spaces in the basal ganglia, and
WMH, as described previously,11 classifying severe
WMHs as a periventricular Fazekas score of 3 and/or a
deep Fazekas score of 2-3.
We assessed dietary salt intake during patient recruit-
ment with the following questions. The first 2 questions
were adapted from a widely used validated food fre-
quency questionnaire,12 and the third question we derived
ourselves as there was no widely used validated ques-
tion to estimate if dietary salt intake had reduced during
adult life:
a. “Do you/your partner add salt to your food during
cooking”: Always/Often/Occasionally/Rarely/Never
b. “Do you add salt to your food at the table”:
Always/Often/Occasionally/Rarely/Never
c. “Have you reduced the amount of salt that you add to
your food, during cooking or at the table, since age 20”:
No take more salt/Yes, I take less salt/I take the same
amount of salt.
These questions were chosen pragmatically to identi-
fy patients who were likely to have a higher salt intake
from those who on average were likely to have a lower
salt intake, rather than to quantify lifetime salt intake.
The gold-standard measurement of current dietary salt
with a detailed food frequency questionnaire or 24-
hour urine would have been impractical in the context
of a large study of patients with a recent stroke.
We measured the urinary sodium : creatinine ratio on
an early-morning urine specimen obtained a minimum
of 1 month post–index stroke using the standard hospi-
tal biochemistry laboratory procedures.
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We performed all statistical analyses using R. We used
Fisher’s exact test to compare dichotomous variables, the
Wilcox test, the Mann–Whitney test for nonparametric con-
tinuous variables, Student’s t-test, and Spearman’s Rho
for parametric tests. As this was an exploratory second-
ary analysis, no power calculation was performed. The
answers to questions a and b were scored as 0-4 with 0
being “never adds salt” and 4 being “always adds salt”;
the score for both questions was added together to make
a “Total Current Salt Score” of 0-8. We summed the Fazekas
deep (0-3) and periventricular (0-3) WMH scores into a
“Total Fazekas Score” (0-6). We performed a multivari-
able logistic regression analysis, the choice of variables
being informed by known associations and univariable
analysis results.
Systematic Review
We searched MEDLINE, EMBASE (from 1947 to present),
LILACS, CINAHL, and psychINFO using search terms
for dietary salt and SVD, and hand-searched conference
abstracts and review article references (search terms in
the Supplement). We contacted authors of those studies
who had measured salt and stroke to ask if they had
Figure 1. Patient recruitment. Abbreviation: MRI, magnetic resonance imaging; TIA, transient ischemic attack.
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unpublished data on stroke subtypes or imaging
variables.
Results
Of the 471 patients referred for the study, 264 were in-
cluded (44 declined, 39 could not have MRI, 71 had a
final diagnosis other than stroke, and 53 were not eligi-
ble for other reasons; Fig 1), 2 did not answer the question
about current salt, and 14 did not answer if they had
reduced salt. Therefore, data from 250 patients were in-
cluded in this analysis. The median age of patients was
67.5, 37% were female and the median NIHSS score was
2 (interquartile range, 2-3) (Table 1). There were 189 pa-
tients who provided a urine specimen; men, younger
patients, and those with lower NIHSS scores were more
likely to provide a urine sample (Table S1).
Table 1. Characteristics of patients, and univariable analysis
All patients
Had not cut down on
salt over lifetime
n = 146
Had cut down on
salt over lifetime
n = 104
P (unadjusted
difference in
salt reduction
Demographic features
Female gender 73 (37%) 60 (41%) 44 (42%) .9
Median age at index stroke 67.5 (IQR 60, 75.25) 66 (IQR 57-72) 66 (IQR 56-75) .6
Dietary salt
Added salt at the table (1-5)* 1 (0,2) 1 (0-3) 0 (0-2) < .001
Added salt during cooking (1-5)* 2 (0,4) 2 (1-4) 1 (0-3) < .001
Median total salt score (IQR) 4 (1-5) 4 (2-6) 2 (0-4) < .001
Stroke-related features
Lacunar subtype 90 (46%) 75 (51%) 37 (36%) .01
Median NIHSS at worse point (IQR) 2 (1,3) 2 (1-3) 2 (2-3) .9
Stroke risk factors
AF 23 (9%) 9 (6%) 14 (13%) .07
Carotid stenosis on either side 26 (10%) 10 (8%) 16 (17%) 1
Smoker or stopped within last 12 months 96 (36%) 65 (45%) 32 (31%) .03
Past medical history
Known diabetes 27 (14%) 13 (9%) 15 (14%) .22
Diagnosis of hypertension prior to index
stroke (or diagnosed at presentation)
142 (72%) 98 (67%) 83 (80%) .03
Median systolic BP at presentation† 150 (27.9) 151 (29) 151 (25) .92
Median diastolic BP at presentation† 83.7 (14.4) 84.4 (14.3) 82 (14.0) .44
Diagnosis of hyperlipidemia prior to index
stroke (or diagnosed at presentation)
85 (43%) 81 (55%) 71 (68%) .05
Ischaemic heart disease 41 (21%) 24 (16%) 25 (24%) .15
Peripheral vascular disease 14 (5%) 8 (5%) 6 (6%) 1
Previous TIA prior to index stroke 28 (11%) 16 (11%) 12 (12%) 1
Previous stroke prior to index stroke 30 (11%) 17 (12%) 13 (13%) .85
Any large vessel disease (IHD, PVD, or
carotid stenosis on either side)
75 (28%) 39 (27%) 36 (35%) .21
Imaging features : SVD score
Median total SVD score 1 (0-2) 1 (0-2) 1 (0-2) .01
At least 1 microbleed 42 (16%) 33 (23%) 9 (9%) .003
PVS in the basal ganglia 123 (47%) 74 (51%) 49 (47%) .61
Periventricular WMH score 1+ 110 (42%) 73 (50%) 37 (36%) .03
At least 1 lacunae on index scan 66 (25%) 46 (32%) 20 (19%) .04
Imaging features: median Fazekas Score
Median periventricular score (IQR) 1 (1,2) 1 (1-2) 1 (1-2) .25
Median deep score (IQR) 1 (1,2) 1 (1-2) 1 (1-2) .45
Median total score (IQR) 3 (2-5) 3 (2-4) 2 (2-4) .37
Abbreviations: AF, atrial fibrillation; BP, blood pressure; IHD, ischaemic heart disease; IQR, interquartile range; NIHSS, National Insti-
tutes of Health Stroke Scale; PVD, peripheral vascular disease; PVS, perivascular spaces; SVD, small vessel disease; TIA, transient ischemic
attack; WMH, white matter hyperintensity.
Bold and Italic indicate statistical significance.
*Median (IQR).
†mm Hg (IQR).
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The 104 patients who indicated that they had reduced
their salt intake in adult life reported adding less salt to
food currently than the 146 patients who had not cut back
(Table 1).
Patients who had reduced dietary salt during adult-
hood were more likely to have a diagnosis of hypertension
(80% versus 67% who had not reduced salt, P = .03) or
hyperlipidemia (71% versus 81% of those who had not
reduced salt, P = .05) and were also less likely to smoke
(31% versus 45%, P = .03).
Patients who had not reduced salt during adult life were
more likely to have the lacunar stroke subtype (51% versus
36%, P = .01), severe WMHs (50% versus 36%, P = .03),
microbleeds (23% versus 9%, P = .003), and a higher total
SVD score.
On multivariable analysis (Table 2), there was still a
significant association between having not reduced salt
and lacunar stroke (odds ratio [OR], 1.90; 95% CI 1.10-
3.29), lacunes (OR, 2.06; 95% CI, 1.09-3.99), severe WMHs
(OR, 2.45; 95% CI, 1.34-4.57), microbleeds (OR, 3.4; 95%
CI, 1.54, 8.21), and high SVD scores (2 or more; OR, 2.17;
95% CI, 1.22-3.9). There was no significant relationship
between salt intake and periventricular spaces on uni-
variate or multivariate analysis.
A higher total current salt score was associated with
a slightly higher total Fazekas13 score on univariable anal-
ysis, but this became nonsignificant when adjusted for
age. There was no other association between total current
salt score and SVD features (Table S3).
The urinary sodium : creatinine ratio was associated
with age, diuretic use, diagnosis of hypertension, and
reduced eGFR. Urinary sodium correlated poorly with
the reported current dietary salt, R = −.01, P = .94 (Fig 2),
or with whether or not the patients had reduced their
salt in adulthood. There was no association between the
urinary sodium/creatinine ratio and SVD features
(Tables S2, S3, and S4).
The systematic literature search found 13,188 poten-
tial titles, of which 2458 were animal studies and 10,684
did not measure either dietary salt or SVD (Fig 3). We
reviewed 46 full-text articles, of which 2 did not measure
salt or SVD, 27 did not provide data on dietary sodium,
and 12 provided data on only all-cause stroke. We con-
tacted 3 authors of studies9,14,15 that had measured all-
cause stroke and salt intake, but they did not have any
data available regarding stroke subtyping. The only study
we identified that provided data on salt and SVD in
humans was the present study when published in a con-
ference abstract and a separate analysis of WMH volume
in the same patient group.7
Discussion
Patients presenting with the lacunar ischemic stroke
subtype were less likely to report that they had reduced
their dietary salt during adult life than patients with cor-
tical stroke. Not reducing salt during adulthood was also
associated with a higher total SVD score and more often
Figure 2. Urinary sodium : creatinine ratio plotted
against “Total Current Salt Score.”
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Table 2. Multivariable analysis of the relationship between having not cut back on salt and different imaging features of small
vessel disease
Model 1 unadjusted
Model 2 adjusted for age
and sex
Model 3, adjusted for age, sex,
and vascular risk factors
Odds ratio of lacunar stroke (versus nonlacunar stroke)
Had not cut back on salt 1.91 (95% CI, 1.15-3.22) 1.88 (95% CI, 1.12-3.19) 1.90 (95% CI, 1.10-3.29)
Age .97 (95% CI, .94-.99) .97 (95% CI, .95-1.00)
Sex (male) .88 (95% CI, .52-1.50) .94 (95% CI, .55-1.60)
Hypertension 1.36 (95% CI, .74-2.53)
Smoking last year 1.27 (95% CI, .71-2.26
AF .56 (95% CI, .17-1.48)
PVD .21 (95% CI, .31-.81)
IHD .90 (95% CI, .44-1.81)
Hyperlipidemia 1.21 (95% CI, .70-2.11)
Odds ratio of having a lacunae on the index scan
Had not cut back on salt 1.93 (95% CI, 1.07-3.57) 1.94 (95% CI, 1.07, 3.62) 2.06 (95% CI, 1.09-3.99)
Age .99 (95% CI, .97, 1.01) 1 (95% CI, .97-1.02)
Male gender .95 (95% CI, .56, 1.6) 2.28 (95% CI, 1.21-4.42)
Known hypertension .57 (95% CI, .3, 1.07)
Smoker (or recent ex-smoker) 1.56 (95% CI, .87, 2.81)
AF .6 (95% CI, .16-1.81)
PVD 2.13 (95% CI, .62-7.05)
IHD 1.4 (95% CI, .64-2.96)
Hyperlipidemia .61 (95% CI, .34, 1.06)
Odds ratio of WMH score 1 on SVD score
Had not cut back on salt 1.81 (95% CI, 1.08, 3.05) 2.29 (95% CI, 1.29-4.14) 2.45 (95% CI, 1.34-4.57)
Age 1.09 (95% CI, 1.06-1.13) 1.09 (95% CI, 1.06-1.13)
Male gender .88 (95% CI, .5-1.56) .82 (95% CI, .45-1.47)
Known hypertension 2.49 (95% CI, 1.25-5.15)
Smoker (or recent ex-smoker) 1.45 (95% CI, .77-2.79)
AF .93 (95% CI, .35-2.54)
PVD 2.1 (95% CI, .63-8.37)
IHD 1.21 (95% CI, .58-2.53)
Hyperlipidemia .87 (95% CI, .47-1.61)
Odds ratio of having EPVL in the basal ganglia
Had not cut back on salt 1.15 (95% CI, .7, 1.91) 1.27 (95% CI, .74-2.2) 1.22 (95% CI, .69-2.16)
Age 1.07 (95% CI, 1.05-1.1) 1.08 (95% CI, 1.05-1.11)
Male gender 1.68 (95% CI, .97-2.92) 1.62 (95% CI, .93-2.85)
Known hypertension 1.39 (95% CI, .73-2.66)
Smoker (or recent ex-smoker) 1.62 (95% CI, .88-3.02)
AF .95 (95% CI, .37-2.56)
PVD .78 (95% CI, .24-2.6)
IHD 1.07 (95% CI, .53-2.19)
Hyperlipidemia .94 (95% CI, .53-1.66)
Odds ratio of having, at least, one microbleed
Had not cut back on salt 3.08 (95% CI, 1.46, 7.14) 3.35 (95% CI, 1.56, 7.89) 3.4 (95% CI, 1.54, 8.21)
Age .99 (95% CI, .96, 1.01) 1 (95% CI, .98, 1.03)
Male gender .98 (95% CI, .58, 1.65) .98 (95% CI, .56, 1.69)
Known hypertension .55 (95% CI, .29, 1.03)
Smoker (or recent ex-smoker) 1.62 (95% CI, .9, 2.95)
AF .58 (95% CI, .22, 1.47)
PVD .9 (95% CI, .27, 3.06)
IHD .83 (95% CI, .41, 1.66)
Hyperlipidemia .59 (95% CI, .33, 1.03)
Odds ratio of having an SVD score of 2 or more
Had not cut back on salt 1.84 (95% CI, 1.1-3.1) 2.07 (95% CI, 1.2-3.6) 2.17 (95% CI, 1.22-3.9)
Age .98 (95% CI, .96-1.01) 1 (95% CI, .97-1.03)
Male gender .97 (95% CI, .58-1.64) 1 (95% CI, .58-1.73)
Known hypertension .55 (95% CI, .28-1.02)
Smoker (or recent ex-smoker) 1.52 (95% CI, .85-2.76)
AF .52 (95% CI, .2-1.31)
PVD .87 (95% CI, .27-2.92)
IHD .87 (95% CI, .27-2.92)
Hyperlipidemia .64 (95% CI, .36-1.11)
Abbreviations: AF, atrial fibrillation; CI, confidence interval; IHD, ischaemic heart disease; PVD, peripheral vascular disease; SVD, small vessel disease.
Bold italics indicate P < .05.
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having lacunes, worse WMHs, or microbleeds. This as-
sociation remained after adjustment, including for
hypertension and age. There was little association between
stroke subtype, or SVD features, and the urine sodium : cre-
atinine ratio or a total current salt score. This is the first
time, to our knowledge, that the relationship between
dietary salt, SVD features (other than WMH volume), and
the lacunar stroke subtype has been reported. It sup-
ports our previous finding that higher reported salt intake
(the total current salt score) was associated with a larger
WMH volume.7
There were limitations. We did not use a detailed dietary
history to assess current salt intake because dietary salt
is acknowledged to be difficult to assess, partly due to
the amount of salt in processed food. It would have been
impractical to perform complex detailed dietary mea-
sures or expect 24-hour urine collections in this group
of patients with recent stroke. The measurement of dietary
sodium in patients after stroke is challenging and diffi-
cult to do without bias,16 any method that involves asking
patients details about their diet is prone to recall bias,
and the use of urine measurements is likely to be
Figure 3. Papers identified for the systematic review.
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confounded by diuretic medication with which many are
prescribed.17 The gold-standard measurements of 24-
hour urinary sodium, or a 5-day weighted food diary,
are likely to be difficult to undertake for patients with
stroke, even minor stroke, given other medical constraints.18
However, it is reasonable to suppose that patients who
report having reduced salt have, on average, taken less
salt over their lifetime than patients who have not reduced
their intake, as having reduced salt intake was also related
to a lower score on the question about current salt intake.
Our dietary questions were intended to group patients
into those with high and low salt intake rather than quan-
tify dietary salt in an exact manner. We performed several
analyses that may have increased the chance of detect-
ing spurious associations with dietary salt. As such, the
findings should be considered exploratory and require
confirmation in another study.
One of the strengths of this study is that all patients
were carefully assessed and thoroughly evaluated, with
a diagnosis of stroke and stroke subtype made by a mul-
tidisciplinary panel and all MRI imaging reviewed by an
experienced neuroradiologist. All such steps used vali-
dated protocols and were blinded to dietary and urinary
salt data.
The association between having not cut down on salt
and SVD may be due to patients who had not cut down
on salt having a greater lifetime salt intake, or it may
be due to confounding from other lifestyle changes that
the patients may have adopted while cutting down on
salt, such as increasing fruit and vegetable intake, stop-
ping smoking, or increasing physical activity. Apart from
smoking, which was included in the multivariable anal-
ysis, we were not able to assess other lifestyle factors.
Additionally, patients who had reduced their salt intake
were more likely to have a diagnosis of hypertension,
which might be expected to increase the SVD burden,
and such patients may have attempted to reduce their
salt intake in response to standard dietary advice for hy-
pertensive patients. The sample was not large enough to
assess for factors such as time since hypertension diag-
nosis on the salt–SVD relationship. The lack of association
with current urinary salt may represent confounding from
the patients who took diuretic medication or a lack of
statistical power to detect a statistically significant dif-
ference. The risk of false positives has been discussed.
The findings should be assessed in larger studies that also
assess lifestyle factors.
However, the results suggest that it would be inter-
esting to assess prospectively the long-term effects of
current dietary salt on future SVD burden while obtain-
ing more detailed measures of current and previous salt
intake. While it is notable that there was no relation-
ship between current salt intake and the BP measured
at presentation, a single measurement in a stressful sit-
uation such as hospital assessment may not be
representative of underlying BP over many years.
The association between having not reduced dietary salt
and SVD is consistent with other cerebrovascular risks
of salt such as all-cause stroke. Future studies should assess
for associations with specific stroke subtypes. Higher dietary
salt intake has also been linked to a more rapid progres-
sion of multiple sclerosis. The effect of dietary salt on
cerebral microvascular endothelial tight junctions and mi-
croglial activation in an experimental model are also worthy
of further investigation.19
As with all novel findings, these cross-sectional anal-
yses should be repeated in other data sets and assessed
in larger prospective studies. The finding that stroke pa-
tients who have not reduced salt are more likely to have
SVD is novel and worthy of further investigations.
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